Cardiex Ltd Market Cap ($13.23 Million)
Market Cap & Net Worth: Cardiex Ltd (CDX)
Cardiex Ltd market cap. Cardiex Ltd (AU:CDX) has a market capitalization of $13.23 Million (AU$18.70 Million) as of November 7, 2026. Listed on the AU stock exchange, this Australia-based company holds position #26183 globally and #1159 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cardiex Ltd's stock price AU$0.03 by its total outstanding shares 550080317 (550.08 Million). Also see CDX cash generation efficiency for how efficiently the company converts equity into cash flow.
Cardiex Ltd Market Cap History (2015–2025)
Cardiex Ltd market cap history from 2015 to 2025. Data shows change from $744.84 Million to $13.23 Million (-35.38% CAGR). Check current stock price of Cardiex Ltd for real-time trading data and today's change.
Cardiex Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cardiex Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Cardiex Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
3.46x
Cardiex Ltd's market cap is 3.46 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $744.84 Million | $5.47 Million | -$1.44 Million | 136.23x | N/A |
| 2016 | $236.99 Million | $5.02 Million | -$4.81 Million | 47.22x | N/A |
| 2017 | $125.29 Million | $4.33 Million | -$4.36 Million | 28.95x | N/A |
| 2018 | $101.00 Million | $4.01 Million | -$2.96 Million | 25.21x | N/A |
| 2019 | $97.50 Million | $3.91 Million | -$2.98 Million | 24.95x | N/A |
| 2020 | $195.00 Million | $4.29 Million | -$3.32 Million | 45.43x | N/A |
| 2021 | $240.30 Million | $5.00 Million | -$5.55 Million | 48.05x | N/A |
| 2022 | $125.37 Million | $4.07 Million | -$11.38 Million | 30.83x | N/A |
| 2023 | $47.02 Million | $4.60 Million | -$19.06 Million | 10.21x | N/A |
| 2024 | $37.75 Million | $10.91 Million | -$6.77 Million | 3.46x | N/A |
Competitor Companies of CDX by Market Capitalization
Companies near Cardiex Ltd in the global market cap rankings as of November 7, 2026. Also see Cardiex Ltd assets under control for a full breakdown of the balance sheet.
Key companies related to Cardiex Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Cardiex Ltd (2015–2025)
Market capitalization of Cardiex Ltd from 2015 to today. Between 2015 and today, Cardiex Ltd's market cap moved from $744.84 Million to $ 13.23 Million, with a yearly change of -35.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | AU$13.23 Million | -64.95% |
| 2024 | AU$37.75 Million | -19.70% |
| 2023 | AU$47.02 Million | -62.50% |
| 2022 | AU$125.37 Million | -47.83% |
| 2021 | AU$240.30 Million | +23.23% |
| 2020 | AU$195.00 Million | +100.00% |
| 2019 | AU$97.50 Million | -3.47% |
| 2018 | AU$101.00 Million | -19.38% |
| 2017 | AU$125.29 Million | -47.13% |
| 2016 | AU$236.99 Million | -68.18% |
| 2015 | AU$744.84 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 24th, 2026 the market cap of Cardiex Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.23 Million USD |
| MoneyControl | $13.23 Million USD |
| MarketWatch | $13.23 Million USD |
| marketcap.company | $13.23 Million USD |
| Reuters | $13.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cardiex Ltd
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more